Eli Lilly and Company
COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T
Last updated:
Abstract:
The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof. Formula (I).
Status:
Application
Type:
Utility
Filling date:
27 Feb 2018
Issue date:
9 Jan 2020